Showing results (41-50 of 1,033) with videos related to
Sort By:
Pageof 104
Interventional Cardiology Clinics|June 6, 2017
Bioresorbable Scaffolds: Clinical Outcomes and ConsiderationsDavide CapodannoCirculation. Cardiovascular Interventions|July 28, 2025
Advances in the Detection and Management of Vulnerable Coronary PlaquesMarco Spagnolo, Daniele Giacoppo, Claudio Laudani, et al.Journal of Clinical Medicine|August 14, 2025
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary InterventionClaudio Laudani, Daniele Giacoppo, Antonio Greco, et al.International Journal of Cardiology|October 20, 2024
Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysisAntonio Greco, Lorenzo Scalia, Claudio Laudani, et al.JACC. Cardiovascular Interventions|November 24, 2022
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-AnalysisGiuseppe Andò, Giulia Azzurra De Santis, Antonio Greco, et al.American Heart Journal|March 12, 2011
Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directionsDavide Capodanno, Corrado TamburinoAnnals of Internal Medicine|November 10, 2015
Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysisGiuseppe Andò, Davide CapodannoJACC. Cardiovascular Interventions|January 25, 2020
How to Define Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves: Facts and MisconceptionsDavide Capodanno, Lars SøndergaardExpert Opinion on Drug Safety|January 31, 2022
Anti-inflammatory strategies for atherosclerotic artery diseaseFederica Agnello, Davide CapodannoProgress in Cardiovascular Diseases|February 26, 2026
Prehabilitation in frail patients undergoing cardiac valve interventionLuigi Cutore, Davide CapodannoPageof 104